Eltrombopag

Tachycardia and lack of efficacy: 3 case reports

    Reactions Weekly volume 1838, page203(2021)Cite this article

    This is a preview of subscription content, access via your institution.

    Access options

    Buy single article

    Instant access to the full article PDF.

    US$ 49.95

    Tax calculation will be finalised during checkout.

    Reference

    1. Ruan J, et al. Eltrombopag is effective in patients with relapse/refractory aplastic anemia-report from a single center in China. Annals of Hematology 99: 2755-2761, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1007/s00277-020-04266-1

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Eltrombopag. Reactions Weekly 1838, 203 (2021). https://doi.org/10.1007/s40278-021-89520-3

    Download citation